Moreover, IgA antibody against EBV early antigen (EA/IgA) is a highly specific marker, which is usually assayed simultaneously with VCA/IgA for the diagnosis of NPC [48]–[50]. The gene discussed is CD79A; the disease is nasopharyngeal carcinoma.